NSAIDS + Corticosteroids Flashcards

0
Q

What are the beneficial and adverse effects of the inflammatory response?

A

Increased blood flow to injured tissue, oedema formation in damaged tissue dilutes noxious stimuli, attraction of leucocytes and macrophages, generation of antibodies, increased supply of nutrients and oxygen. Adverse - significant pain, long lasting hyperalgesia, loss of function, release of mediators may induce a cycle of inflammatory cell attraction and further mediator release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Name the Mediators of Inflammation

A

Amines - histamine, 5-hydroxytryptamine, kinins, complement, cytokines - interleukins, eicosanoids - prostaglandin E2, prostacyclin, Platelet activating factor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the function of histamine?

A

It is released from cells such as mast cells, basophils and eosinophils and causes vascular dilation and increased vascular permeability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the function of 5-HT

A

It causes increased vasoconstriction and is released from cells such as mast cells and platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the function of bradykinin

A

Formed from kininogen in plasma by factor XII, it causes increased vascular dilation and is a mediator of pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Definition of NSAIDS?

A

Agents which inhibit the formation of eicosanoids from arachidonic acid. Prostaglandins and thromboxanes and luekotrienes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the NSAIDS mechanism of action?

A

They inhibit the enzyme cyclo-oxygenase (COX) there are two enzymes - COX-1 and COx-2. COX 2 is a constitutive enzyme. COX-2 is an inducible enzyme produced by inflammatory cells. NSAIDS mainly are non selective reversible inhibitors of COX1 and COX2. They have an analgesic and antipyretic effect centrally and peripherally they are anti inflammatory, analgesic, anti thrombotic, anti endotoxic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Endotoxins and how do NSAIDS affect them?

A

Endotoxins are lipopolysaccharides generated by gram negative bacteria. Endotoxins damage white blood cells and vascular endothelium thus releasing vasoactive mediators. NSAIDS prevent the generation of vasoactive mediators during endotoxaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the Absorption and Distribution of NSAIDS?

A

They are Given orally or parenterally. They are well absorbed after oral administration as they are weak acids (In gut low PH, non ionised). Food may interfere with absorption. Increases some (mavacoxib) decreases others (Flunixin). It is highly protein bound (approaching 99%) It has a small apparent volume of distribution. It accumulates at sites of inflammation. Often has a short half life – but duration of effect is long due to the binding to COX enzyme.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the Metabolism of the NSAIDS

A

Hepatic metabolism, some excretion of unaltered drug (alkaline urine enhances this), some metabolites are active, slow metabolism and excretion in young (up to 6 weeks old) Some display zero order kinetics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the Side effects of Nsaids?

A

Related to the inhibition of Cox-1. GIT ulceration - reduced synthesis of prostaglandins which inhibit gastric acid secretion and promote mucous secretion. Nephrotoxicity - effect of inhibition of prostaglandins on renal blood flow. In face of relative hypovolaemia/hypotension prostaglandins dilate the afferent arteriole and allow activation of RAAS to constrict the efferent arteriole. COX inhibitiion leads to increased apoptosis of medullary interstital cells. Potential to induce hepatic injury. Coagulation affects eg aspirin. COX2 selective agents desirable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Aspirin

A

Hydrolysed to an active moiety - salicylate. It irreversibly binds to cyclo-oxygenase - it has a selectivity for Platelet COX. Its side effects are gastrointestinal erosions, haemorrhage, and emesis. It is oxidised and some is conjugated to glucuronide or sulphate. there are massive species variation in half life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain why Aspirin is a more effective antithrombotic agent at low doses.

A

TXA2 is inhibited at low doses whereas the disaggregatory eicosanoid PGI2 is not. At high doses PGI2 synthesis by endothelial cells inhibited. TXA2 Promotes platelets to stick together and localised vasoconstriction *inhibited at low doses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the Effects / Metabolism of Paracetamol

A
  1. glucuronidation 2.sulphate conjugation 3. N hydroxylation. Pathway 3 yields NABQI. NABQI binds to glutathione. But if glutathione is saturated it binds to hepatic proteins causing necrosis. Paracetamol has an alternative mechanism of action - it is a good antipyretic and analgesic but an inferior anti inflammatory. It interferes with cyclic endoperoxidases rather than cyclo oxygenase enzyme.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe Phenylbutazone

A

More potent anti inflammatory than analgesic. Activity is associated with cyclo oxygenase inhibition. It concentrates in inflammatory exudate. Its absorption is reduced by food. There are very large interspecies differences in kinetics. The active metabolite is oxyphenbutazone. Zero order kinetics - half life varies with dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Carprofen?

A

A poor cyclo-oxygenase inhibitor yet potent anti inflammatory. It is a racemic mix and is COX-1 sparing. It is generally well tolerated, has a good safety profile in dogs. Can be used as a perioperative analgesic with reduced risk of nephropathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the ‘Coxib’ NSAIDS

A

Developed to increase GI safety. Once daily administration they have hepatic metabolism and biliary excretion. e.g Robenacoxib. Mavacoxib is a preferential COX-2 inhibitor given orally as food increases bioavailability. It is highly bound to plasma protein and has an extended half life giving therapeutic levels for one month. Mainly eliminated unchanged in the bile.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the uses of Hyaluronan

A

A ubiquitous molecule. A non sulphated proteoglycan which is naturally occurring and imparts important structural characteristics to synovial fluid ad cartilage. It is classed as a chondroprotective agent. It can be given intra articular and intravenous administration. Used in dogs and horses. It scavenges free radicals and induces PGE2 synthesis and proteoglycan synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are Polysulphated Glycosaminoglycan & pentosan polysulphate??

A

They have a structure similar to heparin. They are for intra articular and intra muscular use in horses and subcut in dogs. They stimulate matrix metalloproteinase production. the drug is not contained in the ccartilage but is excreted by the kidney.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe Matrix Metalloproteinases

A

A family of proteolytic enzymes, which play a role in matrix degradation. They are endogenous inhibitors called TIMPs. MMPS play a role in joint disease. There is a potential role of MMP inhibitors in management of inflammatory joint disease. Tetracyclines are weak inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where are corticosteroids synthesised?

A

The adrenal cortex produces corticosteroids;

  • mineralocorticoids - aldosterone (Zona glomerulosa)
  • Glucocorticoids - cortisol (hydrocortisone) and cortisone (zona fasciculata and reticularis). They are synthesised and released as required. Synthesised from cholesterol obtained from plasma and stored in the adrenal gland.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the Structure of Glucocorticoids.

A

They have a four ring , 21 carbon basic structure. They are all biologically active steroids so have a double bond at C4-5 and a ketone at C3. Substitutions can increase the gluconeogenic potency and decrease the mineralocorticoid activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the pharmacokinetics of Glucocorticoids

A

They are highly protein bound. They bind to albumin and corticotrophin binding globulin. CBG has a high affinity but low capacity and binds only to endogenous corticosteroids apart from prednisolone. Albumin binds to endogenous and synthetic. Hydrocortisone has a short half life (90 minutes). Metabolism occurs in the liver. There is reduction of the C4-5 double bond and conjugation with sulphate or glucuronic acid. It is excreted in the urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the mechanism of action of glucocorticoids?

A

They cross the cell membrane by diffusion and bind to steroid specific cytoplasmic receptors. Receptor steroid complex translocates to the nucleus and increases or decreases the transcription of specific mRNAs and up or down regulates gene expression. Some effects linked to interaction of the steroid receptor complex with transcription activator protein which acts as an enhancer of gene transcription. They inhibit cytokines, cyclo oxygenase and collagenase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the Metabolic Effects of Glucocorticoids.

A

They increase gluconeogenesis, inhibit utilisation of glucose, increase glycogen storage in response (insulin release), cause protein breakdown and reduced synthesis, redistribution of fat, and negative calcium balance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the Systemic effects of Glucocorticoids

A

Elevation of Liver enzymes, induction of parturition/abortion, alteration of CNS function, Mineralocorticoids activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the Anti-inflammatory effects of corticosteroids?

A

Have an effect on blood vessels by decreasing vasodilation and fluid exudation, inflammatory cells by decreasing action of T helper cells, decreasing accumulation of leucocytes, decreasing macrophage activity, decreasing fibroblast function, decreasing function of osteoblasts and increasing osteoclasts, and inflammatory mediators by decreasing production of prostanoids, inhibiting PLA2, decreasing generation of inflammatory cytokines and decreasing histamine release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe the Immune suppressive effects of Glucocorticoids at low and high doses?

A

Low doses - cellular response inhibited lymphocytes, eosinophils, monocytes and basophils. Increase in neutrophils.
High doses - humoral response inhibited.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is addison’s Disease and what are the use of mineralocorticoids in treating it?

A

Addison’s is a deficiency of adrenocortical steroid production. Mineralocorticoid and glucocorticoid deficiency. Animals present collapsed, bradycardic, hyperkalaemic, hyponatraemic and dehydrated. It is treated acutely with hydrocortisone and acutely with fludrocortisone.

29
Q

Name the adverse Effects of Glucocorticoid treatment

A

Gastric ulceration - potentiated by NSAIDS, muscle atrophy, cutaneous atrophy, hyperglycaemia, osteoporotic effect, mineralocorticoid activity resulting in sodium and water retention and loss of potassium, polyuria and polydipsia. Increased susceptibility to infection, laminitis, corneal ulceration, iatrogenic cushings, suppression of HPA

30
Q

What is Iatrogenic Cushings Disease?

A

Cushings - overproduction of glucocorticoids can be due to a pituitary adenoma or due to an adrenal tumour. Iatrogenic cushings can result from prolonged treatment with glucocorticoids. Signs of cushing are polydypsia, polyuria, polyphagia, elevated liver enzymes.

31
Q

What are the beneficial effects of the inflammatory response?

A

Increased blood flow to injured tissue, oedema formation in damaged tissue, dilution of noxious stimuli, attraction of leucocytes and macrophages, generation of antibodies at the site of infection, increased supply of nutrients and oxygen -resolution and return to normal.

32
Q

What is the definition of Non steroidal anti inflammatory drugs and what are the uses of anti-inflammatory drugs?

A

Agents which inhibit the formation of eicosanoids from arachadonic acid, prostaglandins and thromboxanes. They are used to control adverse effects of inflammatory response, anaphylaxis, arthritis/synovitis, endotoxaemia, asthma type disease, anti thrombotic.

33
Q

What is the mechanism of action of the nSAIDS?

A

They inhibit the enzyme cyclo-oxygenase (COX). There are two enzymes - cox-1 and cox-2. Cox-1 is a constitutive enzyme produced in a number of different cell types. Cox-2 is inducible, produced by inflammatory cells. nSAIDS mainly non selective reversible inhibitors of COX-1 and COX-2.

34
Q

Describe the central and peripheral effects of the NSAIDS?

A

Central - analgesic, antipyretic

Peripheral - anti inflammatory, analgesic, anti thrombotic, anti endotoxic, cartilage effects.

35
Q

How May NSAIDS act as antipyretic?

A

The hypothalamus regulates set point of temperature. In pyrexia this set point is elevated - due to IL-1 Mediated release of prostaglandins. nSAIDS stop the formation of prostaglandins.

36
Q

What is endotoxic shock and how to nsaids prevent it?

A

Endotoxins are lipopolysaccharides generated by gram negative bacteria. Endotoxins damage white blood cells and vascular endothelium thus releasing vasoactive mediators. NSAIDs prevent the generation of vasoactive mediators during endotoxaemia.

37
Q

Describe the distribution of the nSAIDS

A

Highly protein bound - approaching 99%. Small apparent volume of distribution often <0.2 l/kg, they accumulate at sites of inflammation. They often have a short half life but duration of effect is long - as they are binding to the COX enzyme.

38
Q

Describe the metabolism of the nSAIDS?

A

They undergo hepatic metabolism. Some excretion of the unaltered drug occurs. (alkaline urine enhances this). Some metabolites are active e.g oxyphenbutazone, salicylate.) Slow metabolism and excretion in young. Some display zero order kinetics

39
Q

What are the side effects of the nSAIDS?

A

They are related to the inhibition of COX-1, GIT ulceration (reduced synthesis of GI prostaglandins which inhibit gastric acid secretion and promote mucous secretion, large intestinal lesions in horses) Nephrotoxicity - Effect of inhibition of prostaglandins on blood flow, PGS dilate afferent arteriole. COX inhibition leads to increased apopptoosis of medullary interstitial cells.

40
Q

Describe the potential drug interactions of the nSAIDS?

A

Two cyclo oxygenase inhibitors - additive efficacy and toxicity. Slower clearance in combination with some other NSAIDS, cimetidine, chloramphenicol. Highly protein bound drugs e.g warfarin and sulphonamides may result in displacement of the drug with lower binding affinity.

41
Q

Describe the uses of aspirin

A

Aspirin is acetyl salicylic acid. It is hydrolysed to its active moiety - salicylate. It irreversibly binds to cyclooxygenase by acetylation. It has a selectivity for platelet COX. Its potential side effects are gastrointestinal erosions, haemorrhage and emesis. It is oxidised and some conjugated to glucuronide or sulphate. Massive species variation in half life. Aspirin is a more effective antithrombotic agent at low doses. TXA2 is inhibited at low dose whereas the disaggregatory eicosanoid PGI2 is not. At high doses PGI2 synthesis by endothelial cells is inhibited.

42
Q

Describe the Metabolism of Paracetamol

A
  1. Glucuronidation 2. Sulphate conjugation. 3. N-hydroxylation. Pathway 3 yields NABQI. NABQI binds to glutathione but if glutathione is saturated it binds to hepatic proteins causing necrosis. Treatment is with N-acetylcysteine, a precursor of glutathione that provides a substrate for pathway 3.
43
Q

How does Paracetamol work?

A

It is grouped with the NSAIDS but has an alternative mechanism of action. It is a good antipyretic and analgesic but inferior anti inflamatory. Paracetamol interferes with cyclic endoperoxidases, whereas normal NSAIDS inhibit cyclo oxygenase.

44
Q

What is phenylbutazone?

A

A more potent anti inflammatory than analgesic. Its activity is associated with cyclo oxygenase inhibition. Concentrates in inflammatory exudates. It can cause protein losing enteropathy in ponies. Absorption is reduced by food. It has a large interspecies differences in kinetics. It has an active metabolite - oxyphenbutazone & zero order kinetics.

45
Q

What is Carprofen?

A

A poor cyclo-oxygenase inhibitor yet potent anti inflammatory. It is a racemic mix and is COX-1 Sparing. It is generally well tolerated and has a good safety profile in dogs compared to 5 other NSAIDS. It can be used as a perioperative analgesic with reduced risk of nephropathy.

46
Q

Describe the Coxibs Robenacoxib and mavacoxib?

A

Robenacoxib has a similar safety and efficacy profile to carprofen. The Coxibs were developed to increase GI safety. Given by once daily administration they undergo hepatic metabolism and biliary excretion. Mavacoxib is a preferential COX-2 inhibitor. Given orally, food increases bioavailability. It is linear kinetics and is highly bound to plasma protein.

47
Q

What is Hyaluronan/hyaluronic acid?

A

A ubiquitous molecule, a non sulphated proteoglycan, naturally occurring, it imparts important structural characteristics to synovial fluid and cartilage. It is classed as a chondroprotective agent. It can be given intra articular and intravenous administration. Used in dogs and horses. It increases proteoglycan synthesis, is a free radical scavenger, decreases leucocyte and macrophage activity, decreases IL-1 induced proteoglcan release and decreases PGE2 synthesis.

48
Q

What is polysulphated glycosaminoglycan & pentosan polysulphate

A

Have a similar structure to heparin. Given intra articular and IM use in horses and SC admin in dogs. Stimulates matrix metalloproteinase production. Drug not retained in cartilage, is excreted by the kidney. The matrix metalloproteinases is a family of proteolytic enzymes which play a role in matrix degradation. Potential role of MMP inhibitors in management of inflammatory joint disease.

49
Q

Where are mineralocorticoids produced?

A

In the adrenal cortex in the zona glomerulosa

50
Q

Where are glucocorticoids produced?

A

Cortisol (hydrocortisone) and corticosterone are produced in the zona fasciculata and reticularis of the adrenal cortex.

51
Q

When/how are corticosteroids produced?

A

Synthesised and released as required they are synthesised from cholesterol obtained from plasma and stored in the adrenal gland.

52
Q

Describe the basic structure of glucocorticoids

A

A four ring, 21 carbon basic structure, all biologically active steroids have a double bond at C4-5 and a ketone at C3. Substitutions can increase the gluconeogenic potency and decrease the mineralocorticoids activity.

53
Q

Describe the Pharmacokinetics of the glucocorticoids

A

They are highly protein bound - to albumin, & corticotrophin binding globulin. CBG has a high affinity but low capacity - for endogenous only glucocorticoids (except prednisolone). Albumin binds to endogenous and synthetic glucocorticoids. Hydrocortisone has a short half life (90 minutes). Metabolism occurs in the liver. Reduction of the C4-5 double bond and conjugation with sulphate or glucuronic acid. They are excreted in the urine. Cortisone and prednisone are inactive and are converted to hydroocortisone and prenisolone.

54
Q

What is the mechanism of action of the glucocorticoids?

A

They cross the cell membrane by diffusion and bind to steroid specific cytoplasmic receptors. The receptor steroid complex translocated to the nucleus and increases or decreases the transcription of specific mRNAs -> up or down regulates gene expression. Some effects are linked to interaction of the steroid receptor complex with transcription activator protein which acts as an enhancer of gene transcription.

55
Q

Name Some proteiins whose synthesis is targeted by glucocorticoids?

A

Induced; Angiotensin converting enzyme, B2 adrenoceptor

Inhibited; cytokines, cyclo oxygenase, collagenase

56
Q

What are the actions of the glucocorticoids?

A

Metabolic effects, systemic effects, anti inflammatory effects, immune suppressive effects.

57
Q

Describe the metabolic effects of the glucocorticoids?

A

Their effects are mainly on carbohydrate and protein metabolism. They increase glucuneogenesis, inhibit utilisation of glucose, (»Hyperglycaemia), increase glycogen storage in response (insulin release), protein breakdown and reduced synthesis, redistribution of body fat, negative calcium balance (decrease absorption and enhance excretion)

58
Q

What are the anti inflammatory effects of glucocorticoid?

A

Pharmalogical concentrations only - act on early and late stages of inflammation, affect all types of inflammatory reactions irrespective of inciting cause, have an effect on blood vessels, inflammatory mediators and inflammatory cells. Decrease vasodilation and fluid exudation in blood vessels.

59
Q

what are the effects on the inflammatory cells by the glucocorticoids?

A

They decrease the action of T helper cells, decrease the accumulation of leucocytes in areas of inflammation, decrease activity of macrophages in combating micro organisms, decrease fibroblast function, decrease function of osteoblasts and increase activity of osteoclasts.

60
Q

What is the effect on inflammatory mediators by the glucocorticoids?

A

They decrease production of prostanoids (Inhibit COX), inhibit PLA2 by inducing the formation of lipocortin, they decrease the generation of inflammatory cytokines and decrease histamine release.

61
Q

what are the immune suppressive effects of the glucocorticoids?

A

In low doses - the cellular response is inhibited, lymphocytes, eosinophils, monocytes and basophils - increase in neutrophils.
In high doses - the humoral response is inhibited.

62
Q

Describe the different formulations of glucocorticoids available?

A

Water soluble salts - ideal for intravenous administration. Phosphate salts and soluble esters. Examples include betamethasone sodium phosphate. Insoluble esters - acetate, phenylproprionate - dexamethasone phenylproprionate.

63
Q

Describe the different routes of administration possible with the glucocorticoids?

A

Topical - eyes, ears skin, C17 aliphatic side chain can influence topical absorption. Acetonide esters well absorbed from the skin and limited systemic access. Opthalmic preparations can cause adrenal suppression. Oral administration - good absorption. Parenteral, inhalational, intra-articular.

64
Q

What are the clinical uses of glucocorticoids?

A

Inflammatory disease - acute (allergic disease) or chronic (osteoarthritis). Immune mediated disease ( may use in combination with other immune suppressive drugs) - immune mediated haemolytic anaemia, myasthenia gravis, immune mediated skin disease. Shock - generally high dose of short acting soluble glucocorticoid. Cerebral oedema. neoplasia - as part of a regimen using additional chemotherapeutic agents. Helps in secndary complications e.g hypercalcaemia.

65
Q

How can steroids be used intra articular?

A

Methylprednisolone - rapid metabolism to MP, very low serum conc., levels maintained for up to 39 days. Adverse effects on cartilage. Triamcinolone acetonide - higher and more prolonged plasma levels, levels in joint undetectable after 2 weeks, no alteration on bone remodelling/fragility.

66
Q

Describe Addison’s disease and the use of mineralocoorticoids in treating it.

A

Addison’s is a deficiency of adrenocortical steroid production - Mineralocorticoid and glucocorticoid deficiency. Animals generally present collapsed, bradycardic, hyperkalaemic, hyponatraemic and dehydrated. It is targeted acutely with hydrocortisone, long term manage with fludrocortisone.

67
Q

What are the adverse effects of glucocorticoid treatment?

A

Gastric ulceration - potentiated by NSAIDS. Muscle atrophy, cutaneous atrophy, hyperglycaemia, osteoporotic effect - decrease absorption and increase excretion of calcium, decreased activity of osteoblasts and increase activity of osteoclasts, degeneration of epiphyseal cartilage in young animals. Mineralocorticoid activity resulting in sodium and water retention and loss of potassium. Polyuria and polydypsia, increased susceptibility to infection, laminitis, corneal ulceration, suppression of HPA, iatrogenic cushings.

68
Q

What is Iatrogenic cushings?

A

Normal Cushings disease is the overproduction of glucocorticoids due to a pituitary adenoma or due to an adrenal tumour. Iatrogenic cushings can result from prolonged treatment with glucocorticoids. Signs of cushings are polydipsia, polyuria, Polyphagia, elevated liver enzymes, pot bellied appearanc.

69
Q

Describe how suppression of the HPA axis occurs.

A

Exogenous steroids have a negative feedback. Suppression of ACTH storage and formation and may cause atrophy of the gland. Sudden termination of the exogenously administered steroid can result in a crisis. Gradual reduction in dose may help to avoid this. Alternate day therapy may help to avoid some of the problems of HPA suppression. Give a short acting glucocorticoid in a short acting formula. Give at time of peak endogenous levels (morning for dogs and evening for cats).